#news #biotech GSK pays iTeos $625M upfront to join Merck, Roche and the rest in TIGIT immuno-oncology race

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: GSK pays iTeos $625M upfront to join Merck, Roche and the rest in TIGIT immuno-oncology race .GSK pays iTeos $625M upfront to join Merck, Roche and the rest in TIGIT immuno-oncology race
ntaylor
Mon, 06/14/2021 – 04:56

from FierceBiotech: Biotech https://ift.tt/3glJBEH